Your browser doesn't support javascript.
loading
Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations.
Souza, José Diogo S; Fassoni-Ribeiro, Maíra; Batista, Rayssa Miranda; Ushirohira, Juliana Mayumi; Zuardi, Antonio W; Guimarães, Francisco S; Campos, Alline C; Osório, Flávia de Lima; Elias, Daniel; Souza, Cacilda S; Fassoni, AndRea A; Hallak, Jaime E C; Crippa, José Alexandre S.
Afiliación
  • Souza JDS; Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Fassoni-Ribeiro M; Department of Dermatology, São Paulo Federal University, São Paulo, Brazil.
  • Batista RM; Division of Dermatology, Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Ushirohira JM; Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Zuardi AW; Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Guimarães FS; National Institute of Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.
  • Campos AC; National Institute of Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.
  • Osório FL; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Elias D; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Souza CS; Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Fassoni AA; National Institute of Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.
  • Hallak JEC; Division of Dermatology, Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Crippa JAS; Division of Dermatology, Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Front Pharmacol ; 13: 881617, 2022.
Article en En | MEDLINE | ID: mdl-35662726
Cannabidiol (CBD) is a non-psychotomimetic constituent of the Cannabis plant, with potential therapeutic properties for many physical and neuropsychiatric conditions. Isolated CBD has been suggested to have favorable safety and tolerability. Although CBD-related rash is described, few case reports are well documented in the literature, and usually, CBD was used concomitantly with other medications. Thus, we report four women who presented a skin rash after ongoing CBD use. Other causes of these skin rashes were ruled out after conducting an extensive viral and serological detection panel, and three patients had their lesions biopsied. Two patients were re-exposed to the vehicle (MCT) without developing a new skin rash. Therefore, clinicians must be aware of this potential adverse effect of CBD use.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Suiza